MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
19.00
-5.03
-20.93%
After Hours: 19.00 0 0.00% 17:30 05/08 EDT
OPEN
18.58
PREV CLOSE
24.03
HIGH
19.53
LOW
18.28
VOLUME
1.98M
TURNOVER
--
52 WEEK HIGH
31.26
52 WEEK LOW
17.03
MARKET CAP
837.77M
P/E (TTM)
9.34
1D
5D
1M
3M
1Y
5Y
1D
AMPHASTAR PHARMACEUTICALS, INC <AMPH.O>: PIPER SANDLER CUTS TARGET PRICE TO $21 FROM $25
Reuters · 4h ago
Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue
Simply Wall St · 2d ago
Amphastar Balances Margin Pain With Pipeline Gains
TipRanks · 2d ago
Amphastar downgraded to Hold from Buy at Needham
TipRanks · 2d ago
Amphastar cut to Hold at Needham after ‘disappointing’ results
TipRanks · 2d ago
Amphastar reports Q1 EPS 42c, consensus 71c
TipRanks · 2d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2d ago
This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Benzinga · 2d ago
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredient (API) products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers. The Company manufactures and sells over 25 prescription pharmaceutical products, and one over-the-counter product, Primatene MIST. Its marketed products include BAQSIMI (glucagon) nasal powder 3mg, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone, Cortrosyn, Amphadase, and Epinephrine injection. It manufactures and sells two API products: Recombinant Human Insulin (RHI API) and porcine insulin API. It is also focused on generic and proprietary product candidates in the injectable, inhalable, topical, and intranasal markets.

Webull offers Amphastar Pharmaceuticals, Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.